Manila Times
TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Te
1731102266 Philippines - 2 weeks ago
Premium home retailer unveils its largest retail location in the stateBOSTON HEIGHTS, Ohio, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Arhaus, a leader in arti
1731102259 Philippines - 2 weeks ago
VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) ("Ascot” or the "Company”) is pleased
1731102255 Philippines - 2 weeks ago
PORTLAND, Ore., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ: RDUS) today announced the appointment of Marc Hathhorn as Executive
1731102252 Philippines - 2 weeks ago
AUM: $1.34 billion at September 30, 2024 Book Value per share ended the quarter at $42.02 Returned $45.9 million to shareholders through dividends de
1731102246 Philippines - 2 weeks ago
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Bagsværd, Denmark, 8 November 2024 - This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's
1731102240 Philippines - 2 weeks ago
Orlando, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- CNL Strategic Capital, LLC (CNL Strategic Capital or the Company) seeks to provide current income and
1731102229 Philippines - 2 weeks ago
AUCATZYL is the first CAR T therapy approved by the FDA with no requirement for a REMS program (Risk Evaluation Mitigation Strategy)Approval based on
1731102225 Philippines - 2 weeks ago
GUADALAJARA, Mexico, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (the "Company” or "GA
1731101134 Philippines - 2 weeks ago
CHICAGO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Tidal Financial Group today announced that the Board of Trustees of Tidal Trust II (the Trust) has approved
1731101131 Philippines - 2 weeks ago
New York, New York, Nov. 08, 2024 (GLOBE NEWSWIRE) -- New Providence Acquisition Corp. II (Nasdaq: NPAB) (the "Company”) announced today that its bo
1731101130 Philippines - 2 weeks ago
ADELAIDE, Australia and CAMBRIDGE, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage
1731101126 Philippines - 2 weeks ago
PITTSBURGH, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Matthews International Corporation (Nasdaq GSM: MATW) today announced plans to release its fourth quarte
1731101122 Philippines - 2 weeks ago
STAMFORD, Conn., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Grayscale Investments® ("Grayscale”), an asset management firm with over a decade of expertise i
1731101119 Philippines - 2 weeks ago
Notification of share transaction by Director of Millicom (Tigo) sharesLuxembourg, November 8, 2024 - Millicom International Cellular S.A. ("Millicom"
1731101102 Philippines - 2 weeks ago
ANN ARBOR, Mich., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on November 7, 2024, the Company granted four new emp
1731101099 Philippines - 2 weeks ago
NEWTOWN, Pa., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA) announces that Max Wygod, Chief Executive Officer and Executive Chairman, a
1731101095 Philippines - 2 weeks ago
Singapore, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Nova Vision Acquisition Corp. (NASDAQ: NOVV, the "Company”), a special purpose acquisition company, ann
1731101090 Philippines - 2 weeks ago
Aptose and Hanmi Pharmaceutical Co-developing Triplet Therapy of Tuspetinib with Azacitidine and Venetoclax for Newly Diagnosed AMLSAN DIEGO and TORON
1731101087 Philippines - 2 weeks ago
WOBURN, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the developme
1731101084 Philippines - 2 weeks ago